Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

DNABW

Ginkgo Bioworks Holdings, Inc.

CIK 0001830214 · NYSE

NYSEHealth CareBiological Products, (No Diagnostic Substances)
$0.00
↑ 0.00 (0.00%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BearishOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
Not covered
P/E Ratio
Not covered
EPS
-5.64
Dividend Yield
Not covered
52W Position
2%
Beta
5.86

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
Not covered
P/S
Not covered
EV/Revenue
Not covered
ROE
-68.7%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 2%
$0.00$0.02

Latest Financials

2025-12-31 FY
Revenue
$170.16M
Net Income
-$312.76M
Total Assets
$1.12B
Free Cash Flow
-$178.72M

Recent news